NCT07789821

Brief Summary

This study investigates whether low-energy laser light therapy applied to the skin (photobiomodulation, PBM) can speed up recovery of sensation in the lower lip, chin, and cheek area following jaw surgery (bimaxillary orthognathic surgery). Numbness and altered sensation in these areas are common and expected side effects of jaw surgery, affecting approximately one third of patients at 12 months without active treatment. There is currently no proven non-invasive treatment to accelerate nerve recovery after jaw surgery. Eligible participants who develop numbness after jaw surgery will be randomly assigned to receive either active PBM laser treatment or an inactive sham laser treatment (6 sessions over 3 weeks). Neither the participant nor the assessor measuring recovery will know which treatment was received. All participants also receive standard postoperative care. The study aims to determine whether active PBM significantly reduces the time to functional sensory recovery compared with sham treatment, and to characterise recovery patterns using a standardised multicomponent neurosensory assessment battery over 12 months.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
28mo left

Started Sep 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 27, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

August 27, 2026

Status Verified

August 1, 2026

Enrollment Period

2.3 years

First QC Date

August 24, 2026

Last Update Submit

August 24, 2026

Conditions

Keywords

inferior alveolar nerve injuryphotobiomodulationNeurosensory disturbance following orthognathic surgeryInfraorbital nerve injury

Outcome Measures

Primary Outcomes (1)

  • Time to functional sensory recovery (FSR) in the inferior alveolar nerve (IAN) distribution

    FSR is defined as simultaneous achievement of all three of: (1) VAS = 0 across lateral IAN territory bilaterally using standardised blunt 21-gauge needle shaft; (2) Semmes-Weinstein monofilament ≤3.61 detectable at lateral IAN test sites bilaterally; and (3) Disk-Criminator static two-point discrimination positive at ≤15 mm at lateral IAN test sites bilaterally. Mandibular central incisor regions excluded due to bilateral innervation. The date of the first assessment at which all three criteria are simultaneously met is recorded as time to FSR.

    12 months

Secondary Outcomes (2)

  • Time to functional sensory recovery (FSR) in the infraorbital nerve (ION) distribution

    12 months

  • OHIP-14

    12 months

Study Arms (2)

Intervention

EXPERIMENTAL

Photobiomodulation

Device: Nd:YAG laser photobiomodulation

Control

SHAM COMPARATOR

Sham laser

Other: Sham laser

Interventions

Fotona Laser, Lightwalker, Nightlase

Intervention

Control

Control

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 21-80 years and above at time of orthognathic surgery.
  • Underwent bimaxillary orthognathic surgery (SSRO and Le Fort I osteotomy), without genioplasty
  • Willing and able to comply with the full 12-month follow-up schedule comprising 12 visits.

You may not qualify if:

  • Systemic diseases known to impair peripheral nerve regeneration, including diabetes mellitus (any type), peripheral neuropathy of any aetiology, multiple sclerosis, or other demyelinating disorders.
  • Pregnant women are excluded
  • Patients with cognitive impairment are excluded
  • History of hypersensitivity or adverse reaction to laser therapy of any type.
  • Surgical complication directly attributable to the orthognathic procedure that required reoperation or microsurgical nerve repair, as these represent a fundamentally different injury severity and recovery trajectory from the neurapraxic and axonotmetic injuries targeted by this study.
  • Genioplasty performed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kayim YT, Ozkan N, Akbulut N, Kirtiloglu T. Nd:YAG and Diode Laser Biostimulation in Infraorbital and Inferior Alveolar Neurosensory Recovery After Orthognathic Surgery: A Randomized Clinical Study. J Oral Maxillofac Surg. 2026 May 20:S0278-2391(26)00402-7. doi: 10.1016/j.joms.2026.05.062. Online ahead of print.

    PMID: 42229538BACKGROUND

Central Study Contacts

Chee Weng Yong, BDS, MDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Biostatistician
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study uses a parallel assignment model with two arms (active photobiomodulation and sham control) in a 1:1 ratio.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2026

First Posted

August 27, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

August 27, 2026

Record last verified: 2026-08